Krebs Biochemicals Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

The Krebs Biochemicals stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Krebs Biochemicals share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Krebs Biochemicals stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

What Analysts Predict for Krebs Biochemicals Stock in 2026

Analyst consensus on the Krebs Biochemicals stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.

Brokerage	Rating	Krebs Biochemicals Stock Prediction (Rs)	Updated
JM Financial	Neutral	Rs 79	2026
Kotak Securities	Neutral	Rs 73	2026
Analyst Consensus	—	Rs 76	2026

The analyst target range for Krebs Biochemicals reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Krebs Biochemicals stock forecast from the current price of Rs 66 may or may not be realised by end of 2026.

Krebs Biochemicals Company Overview

Krebs Biochemicals and Industries is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Krebs Biochemicals stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk.

Metric	Value
NSE Ticker	KREBSBIO
Sector	Pharmaceuticals and Healthcare
CMP	Rs 66 (2026)
52 Week High	Rs 91.9
52 Week Low	Rs 38.3
Market Cap	Rs 142 Cr
P/E Ratio
Krebs Biochemicals Stock Prediction Consensus (12M)	Rs 76

Krebs Biochemicals Stock Prediction by Time Horizon

Analysts split the Krebs Biochemicals share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Krebs Biochemicals Stock Prediction

The near-term Krebs Biochemicals stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 66 are being watched closely. A short-term Krebs Biochemicals share price prediction carries the most uncertainty of any time horizon.

12-Month Krebs Biochemicals Stock Prediction

JM Financial targets Rs 79 (Neutral) and Kotak Securities targets Rs 73 (Neutral). Most desks refresh their Krebs Biochemicals stock forecast within two to four weeks of each quarterly earnings print. The Krebs Biochemicals share price prediction should be verified against the most recent analyst reports.

Long-Term Krebs Biochemicals Stock Prediction

The long-term outlook for Krebs Biochemicals is built on assumptions about demand recovery, margin expansion and revenue diversification in the Pharmaceuticals and Healthcare sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.

Krebs Biochemicals Stock Forecast: Key Factors

The following four factors appear consistently in analyst research on Krebs Biochemicals and are the primary inputs into the bull and bear case scenarios.

US Generic Revenue

US generics revenue is the most watched metric in the Krebs Biochemicals stock forecast. USFDA approval timelines and price erosion rates directly affect the Krebs Biochemicals share price prediction from most research desks.

Domestic Formulations Growth

Domestic formulation growth provides a stable base that supports the Krebs Biochemicals stock prediction even when export growth faces headwinds.

R&D Pipeline

The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Krebs Biochemicals share price prediction. New product approvals are cited as catalysts for the Krebs Biochemicals stock prediction.

EBITDA Margin

Sustained EBITDA margin expansion is typically the basis for the bullish Krebs Biochemicals stock forecast. Margin recovery strengthens the Krebs Biochemicals share price prediction from most research desks.

Krebs Biochemicals Stock Prediction: Bull and Bear Scenarios

Scenario	Krebs Biochemicals Stock Prediction	Key Conditions
Bull Case	Rs 79	Strong execution, margin improvement, favourable macro and sector re-rating
Base Case	Rs 76	Steady performance, gradual recovery, margins hold, growth on track
Bear Case	Rs 38.3	Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Krebs Biochemicals stock forecast of Rs 79 assumes most positive variables converge. The base case of Rs 76 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Krebs Biochemicals Stock Story

Analyst reviews of the Krebs Biochemicals share price prediction highlight the company’s core strengths in Pharmaceuticals and Healthcare alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Krebs Biochemicals is built on real business strengths set against real risks.

Key Risks to the Krebs Biochemicals Stock Prediction

USFDA Regulatory Risk

Import alerts and warning letters from the USFDA are the most significant risks to the Krebs Biochemicals stock prediction. A facility closure would force an immediate sharp revision to the Krebs Biochemicals share price prediction.

Price Erosion in the US

Pricing pressure in US generics compresses the revenue per product and affects the Krebs Biochemicals stock forecast. Aggressive price erosion pushes the Krebs Biochemicals share price prediction toward the bear case.

R&D Execution Risk

Delays in clinical trials or approval failures affect the Krebs Biochemicals stock prediction. The Krebs Biochemicals share price prediction is particularly sensitive to key pipeline asset announcements.

Currency Risk

A strengthening rupee against the dollar reduces export realisation and affects the Krebs Biochemicals stock forecast. Currency risk is embedded in conservative Krebs Biochemicals share price prediction models.

How to Monitor the Krebs Biochemicals Stock Forecast

Track the Krebs Biochemicals share price prediction consensus quarterly. After every earnings release, most brokerages revise their Krebs Biochemicals stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Krebs Biochemicals is improving or deteriorating.

Compare the current price of Rs 66 with the analyst target range of Rs 79 to Rs 73. A wide target band reflects genuine uncertainty on Krebs Biochemicals, so position size should reflect that range rather than the midpoint alone.

Review the Krebs Biochemicals share price prediction every quarter against key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Krebs Biochemicals Fundamentals on the Univest Screener

Conclusion

The Krebs Biochemicals stock prediction for 2026 reflects the analyst community’s assessment of Krebs Biochemicals and Industries’s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 79 while Kotak Securities has a Neutral rating with a target of Rs 73, giving an analyst consensus of Rs 76.

The Krebs Biochemicals stock forecast is set against near-term risks that make the Krebs Biochemicals share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Krebs Biochemicals share price target changes over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Krebs Biochemicals in real time.

Frequently Asked Questions on Krebs Biochemicals Stock Prediction 2026

What is the Krebs Biochemicals stock prediction for 2026?

Ans. The Krebs Biochemicals stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 76. All estimates may or may not be achieved.

Is the Krebs Biochemicals stock prediction bullish or bearish?

Ans. JM Financial has a Neutral rating with target Rs 79. Kotak Securities has a Neutral rating with target Rs 73. The Krebs Biochemicals stock forecast reflects genuine analyst diversity of opinion.

What is the Krebs Biochemicals share price prediction based on fundamentals?

Ans. The Krebs Biochemicals share price prediction rests on the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking Krebs Biochemicals closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Krebs Biochemicals stock prediction?

Ans. The long-term outlook assumes Krebs Biochemicals sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 76 is the nearest reliable anchor point.

What are the key risks to the Krebs Biochemicals stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Krebs Biochemicals should be read alongside its risk assumptions.

What does the Krebs Biochemicals stock forecast say for 2026?

Ans. JM Financial: Neutral target Rs 79. Kotak Securities: Neutral target Rs 73. These Krebs Biochemicals share price prediction estimates may or may not prove accurate.

Where can I track the latest Krebs Biochemicals stock prediction?

Ans. Track the latest analyst targets and price movements for Krebs Biochemicals on the NSE and BSE websites and on the Univest app and screener for live data.